Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

-10.90 (-0.88%)

< Home < Back

Dr. Reddy's receives EIR from USFDA for closure of inspection

Date: 21-02-2022

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) indicating closure of the inspection at its formulations manufacturing facilities (FTO 7 & FTO 9) at Duvvada in Visakhapatnam.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.